Showing 1 posts of 1 posts found.
Job switches were the theme of this week as AstraZeneca lost three, high levels executives to biotechs amid a restructuring …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement